Identical to kai-9531 solution for injection without active drug, KAI-9531, KAI-9531, KAI-9531 clinical trials

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living with Obesity or Overweight and Diabetes

This study is looking into a new treatment called KAI-9531 for people who are overweight or have obesity and also have diabetes. Researchers want to see if this new medicine can help people lose weight and improve their blood sugar over about a year and a half.